Quick Answer
Aquestive Therapeutics, Inc. reported Total Assets of $160.43 million for fiscal year 2025.
Aquestive Therapeutics, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $160.43M | +58.2% |
| 2024 | $101.42M | +76.6% |
| 2023 | $57.42M | +0.6% |
| 2022 | $57.07M | -7.9% |
| 2021 | $61.99M | -1.4% |
| 2020 | $62.88M | -19.9% |
| 2019 | $78.48M | -9.6% |
| 2018 | $86.85M | +101.4% |
| 2017 | $43.12M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $163.56M | +48.7% | +74.6% |
| June 30, 2025 | $93.70M | -20.3% | -8.3% |
| March 31, 2025 | $102.23M | -21.1% | +0.8% |
| December 31, 2024 | $101.42M | +76.6% | -7.8% |
| September 30, 2024 | $109.96M | +85.0% | -6.5% |
| June 30, 2024 | $117.61M | +106.3% | -9.2% |
| March 31, 2024 | $129.52M | +111.3% | +125.6% |
| December 31, 2023 | $57.42M | +0.6% | -3.4% |
- Aquestive Therapeutics, Inc. showed an increase of +58.2% in Total Assets compared to the prior fiscal year.
- Over the 2017–2025 period, Aquestive Therapeutics, Inc.’s total assets has grown by 272.1% (from $43.12 million to $160.43 million).
- The most recent figure is from Aquestive Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 4, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: